Side-by-side comparison of price performance, valuation, growth, profitability, analyst targets and technical trend.
| Metric | CLS | APH |
|---|---|---|
| Price | $370.80 | $86.06 |
| Change today | ▲ 2.59% | ▲ 2.09% |
| Market cap | $46.22B | $212.22B |
| Return, 3 months | – | -0.1% |
| Return, year to date | – | +27.8% |
| Return, 1 year | – | +38.8% |
| P/E (TTM) | 38.5 | 43.0 |
| P/B | 18.6 | 13.7 |
| P/E percentile vs own 5y | 78th | 63rd |
| Dividend yield | – | 0.53% |
| Revenue growth (YoY, latest qtr) | +62.4% | +55.0% |
| Net profit growth (YoY) | +74.8% | +62.1% |
| Gross margin | 12.0% | 38.5% |
| Operating margin | 8.8% | 27.7% |
| Net margin | 7.2% | 17.7% |
| Return on equity | 52.7% | 38.1% |
| Analyst target vs. price | +24.5% | +17.0% |
| Analyst buy share | 100% | 89% |
| RSI (14) | – | 58 |
| 30-day volatility | – | 35.7% |
| Max drawdown, 1 year | – | -28.2% |
| Trend read | – | Strong uptrend |
| Analyst consensus | Buy | Buy |
Green cells mark the best value in each row where "better" is clear-cut (lower P/E, higher margin). That is a reading of the numbers, not a recommendation. Financials are in each company's reporting currency.
